THE BCL-2 ANTAGONIST ABT-737 IS HIGHLY EFFECTIVE ON PRIMARY ACUTE LYMPHOBLASTIC LEUKEMIA CELLS

被引：0
|
作者：
Decandia, S. [1 ]
Ricciardi, M. R. [1 ]
Santinelli, S. [1 ]
De Cave, F. [1 ]
Gregorj, C. [1 ]
Bergamo, P. [2 ]
Libotte, F. [1 ]
Vitale, A. [1 ]
Petrucci, M. T.
Milella, M. [1 ,2 ]
Foa, R. [1 ]
Tafuri, A. [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Div Hematol, Rome, Italy
[2] Regina Elena Inst Canc Res, Med Oncol A, Rome, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P109
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [1] The BCL-2 antagonist ABT-737 is highly effective on primary acute lymphoblastic leukemia cells
    Ricciardi, Maria Rosaria
    Gregorj, Chiara
    De Cave, Fabiana
    Bergamo, Paola
    Decandia, Samantha
    Santinelli, Ara
    Vitale, Antonella
    Petrucci, Maria Teresa
    Milella, Michele
    Foa, Robert
    Tafuri, Agostino
    BLOOD, 2007, 110 (11) : 53A - 53A
  • [2] Effective cell killing of primary acute lymphoblastic leukemia cells by the BCL-2 antagonist ABT-737
    Tafuri, A.
    Ricciardi, M. R.
    Gregorj, C.
    De Cave, F.
    Santinelli, S.
    Bergamo, P.
    Decandia, S.
    Vitale, A.
    Petrucci, M. T.
    Milella, M.
    Foa, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 5 - 6
  • [3] BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia
    Moore, Victoria Del Gaizo
    Schlis, Krysta D.
    Sallan, Stephen E.
    Armstrong, Scott A.
    Letai, Anthony
    BLOOD, 2008, 111 (04) : 2300 - 2309
  • [4] Preclinical Study to Sensitize Acute Lymphoblastic Leukemia Primary Cells by Combined mTOR and BCL-2 Inhibition with CCI-779 and ABT-737
    Ricciardi, Maria Rosaria
    Decandia, Samantha
    Bergamo, Paola
    De Benedictis, Cinzia
    Vitale, Antonella
    Testi, Anna Maria
    Fei, Joanna
    Petrucci, Maria Teresa
    Milella, Michele
    Foa, Robin
    Tafuri, Agostino
    BLOOD, 2009, 114 (22) : 409 - 409
  • [5] Enhancement of the Sensitivity of the Acute Lymphoblastic Leukemia Cells to ABT-737 by Formononetin
    Abbasi, Yusef
    Pooladi, Marziyeh
    Nazmabadi, Roya
    Amri, Jamal
    Abbasi, Helia
    Aghabeygi, Razieh
    Karami, Hadi
    INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 2024, 13 (03) : 259 - 271
  • [6] BCL-2 antagonist ABT-737 induces apoptosis in CLL cells by disrupting a BIM:BCL:2 complex
    Moore, Victoria D.
    Brown, Jennifer
    Certo, Michael
    Letai, Anthony G.
    CANCER RESEARCH, 2006, 66 (08)
  • [7] Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A
    Pietro E. Cippà
    Jivko Kamarashev
    Jin Chen
    Anna K. Kraus
    Stephan Segerer
    Laurence Feldmeyer
    Thomas Fehr
    Apoptosis, 2013, 18 : 315 - 323
  • [8] Radiochemosensitization of primary glioma stem cells by the Bcl-2/Bcl-xL inhibitor ABT-737
    Dheenadayalan, R.
    Firat, E.
    Niedermann, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 118 - 118
  • [9] Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A
    Cippa, Pietro E.
    Kamarashev, Jivko
    Chen, Jin
    Kraus, Anna K.
    Segerer, Stephan
    Feldmeyer, Laurence
    Fehr, Thomas
    APOPTOSIS, 2013, 18 (03) : 315 - 323
  • [10] Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A
    Cippa, P.
    Kamarashev, J.
    Segerer, S.
    Chen, J.
    Kraus, A. K.
    Bardwell, P. D.
    Feldmeyer, L.
    Fehr, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S128 - S128
12345